GreenLight Biosciences is a bio-production platform producing RNA solutions for the agriculture, human health, and ingredient sectors. GreenLight harnesses the power of RNA to address the leading issues our planet faces - from public health crisis to sustainable food production for the earth’s growing population. GreenLight imagines solutions that work with nature, not against it.
Andrey J Zarur
CEO and Founder
GreenLight Biosciences to Go Public in SPAC Deal
GreenLight Biosciences will become publicly listed through a business combination with SPAC Environmental Impact Acquisition Corp.
IN THE NEWS
RNA Tech Firm GreenLight Biosciences to Go Public in $1.5 Billion SPAC Deal
Company aims to increase the accessibility of mRNA vaccines while producing RNA-based pesticide alternatives
Wall Street Journal